New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.
作者信息
Thatcher N
机构信息
Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester.
出版信息
Thorax. 1992 Feb;47(2):119-26. doi: 10.1136/thx.47.2.119.
Abstract
摘要
相似文献
1
New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.肺癌的新视角。4. 造血生长因子与肺癌治疗
Thorax. 1992 Feb;47(2):119-26. doi: 10.1136/thx.47.2.119.
2
[Hematopoietic growth factors in the limelight. New actors on the pharmacotherapeutic stage].[造血生长因子备受瞩目。药物治疗舞台上的新角色]
Ned Tijdschr Geneeskd. 1991 Mar 9;135(10):407-9.
3
In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.造血生长因子与循环祖细胞的体内生物学特性及治疗潜力
Semin Oncol. 1992 Aug;19(4):422-31.
4
The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.造血生长因子在骨髓增生异常综合征治疗中的作用。
Hematol Oncol. 1993;11 Suppl 1:32-5.
5
Treatment of myelodysplastic syndromes with hemopoietic growth factors.造血生长因子治疗骨髓增生异常综合征
Semin Oncol. 1992 Feb;19(1):106-14.
6
[Use of hematopoietic growth factors].[造血生长因子的应用]
Duodecim. 1995;111(8):733-40.
7
[Hematopoietic growth factors. Current status of therapy].[造血生长因子。治疗现状]
Internist (Berl). 1994 Apr;35(4):395-400.
8
Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.造血生长因子在骨髓增生异常综合征中的临床应用。
Semin Hematol. 1996 Jul;33(3):186-95.
9
A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.欧洲视角下血液肿瘤中的造血生长因子：欧洲癌症研究与治疗组织（EORTC）专家会议报告
Eur J Cancer. 1997 Oct;33(11):1732-46. doi: 10.1016/s0959-8049(97)00222-0.
10
Hematopoietic growth factor therapy of myelodysplastic syndromes.骨髓增生异常综合征的造血生长因子治疗
Leuk Lymphoma. 1993;11 Suppl 2:65-9. doi: 10.3109/10428199309064264.
引用本文的文献
1
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.一项三臂III期随机试验，在广泛期小细胞肺癌患者中评估血液学生长因子支持下的加速化疗或口服抗生素。
Br J Cancer. 2001 Nov 16;85(10):1444-51. doi: 10.1054/bjoc.2001.2114.
本文引用的文献
1
Reduced erythropoietin levels as a cause of anaemia in patients with lung cancer.促红细胞生成素水平降低作为肺癌患者贫血的一个原因。
Eur J Cancer Clin Oncol. 1986 Apr;22(4):511-4. doi: 10.1016/0277-5379(86)90120-3.
2
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.重组人粒细胞巨噬细胞集落刺激因子对大剂量化疗及自体骨髓移植后造血重建的影响
N Engl J Med. 1988 Apr 7;318(14):869-76. doi: 10.1056/NEJM198804073181401.
3
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.重组人粒细胞巨噬细胞集落刺激因子对化疗所致骨髓抑制的影响。
N Engl J Med. 1988 Sep 8;319(10):593-8. doi: 10.1056/NEJM198809083191001.
4
WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.
J Clin Oncol. 1987 Apr;5(4):574-8. doi: 10.1200/JCO.1987.5.4.574.
5
WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial.WR-2721预防环磷酰胺血液学毒性：一项对照II期试验。
J Clin Oncol. 1986 Apr;4(4):584-8. doi: 10.1200/JCO.1986.4.4.584.
6
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy.粒细胞集落刺激因子对细胞毒性化疗所致中性粒细胞减少的影响。
Lancet. 1988 Mar 26;1(8587):667-72. doi: 10.1016/s0140-6736(88)91475-4.
7
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.重组人粒细胞集落刺激因子用于小细胞肺癌强化化疗患者的Ⅰ/Ⅱ期研究
Br J Cancer. 1987 Dec;56(6):809-13. doi: 10.1038/bjc.1987.295.
8
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.通过皮下注射粒细胞集落刺激因子并优化治疗剂量和疗程来治疗化疗引起的中性粒细胞减少症。
J Clin Oncol. 1989 Oct;7(10):1554-62. doi: 10.1200/JCO.1989.7.10.1554.
9
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.每日短时间输注重组人粒细胞巨噬细胞集落刺激因子（rhGM-CSF）——一项I期剂量毒性研究。
Br J Cancer. 1989 Jan;59(1):142-5. doi: 10.1038/bjc.1989.28.
10
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?自体血液与骨髓细胞联合移植后快速而完全的造血重建。高剂量放化疗的作用在改变？
Hematol Oncol. 1989 Mar-Apr;7(2):139-48. doi: 10.1002/hon.2900070205.
Zotero 插件